PRP
Precipio
Stock
Stock
Ticker: PRPO
PRPO
Price
Price
CHART BY
Frequently asked questions
What is Precipio's market capitalization?
The market capitalization of Precipio is $38.27M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Precipio?
Precipio's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.685. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Precipio's stock?
Currently, 1 analysts cover Precipio's stock, with a consensus target price of $19.00. Analyst ratings provide insights into the stock's expected performance.
What is Precipio's revenue over the trailing twelve months?
Over the trailing twelve months, Precipio reported a revenue of $27.20M.
What is the EBITDA for Precipio?
Precipio's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $293.00K. EBITDA measures the company's overall financial performance.
What is the free cash flow of Precipio?
Precipio has a free cash flow of $789.00K. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Precipio have, and what sector and industry does it belong to?
Precipio employs approximately 61 people. It operates in the Health Care sector, specifically within the Medical/ Nursing Services industry.
What is the free float of Precipio's shares?
The free float of Precipio is 1.57M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $38.27M
- EPS (TTM)
- -$0.685
- Free Float
- 1.57M
- Revenue (TTM)
- $27.20M
- EBITDA (TTM)
- $293.00K
- Free Cashflow (TTM)
- $789.00K
Pricing
- 52W span
- $17.29$33.50
Analyst Ratings
The price target is $19.00 and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. It operates through the following business divisions: Pathology Services and Products. The Pathology Services division provides specialized cancer diagnostic testing services to physicians, hospitals, and laboratories. The Products divisions develops and commercializes proprietary assays designed for use by clinical laboratories. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.
- Employees
- 61
- Industries
- Medical/ Nursing Services
- Sector
- Health Care
Identifier
- Primary Ticker
- PRPO
Fundamentals & EOD data from FactSet